Is Watch-and-Wait Ready for Prime Time?: It Depends on Priming of the Multidisciplinary Care Team

Affiliations

Comment

Charles R Thomas Jr. JAMA Oncol. 2019.

. 2019 Apr 1;5(4):e185895.

doi: 10.1001/jamaoncol.2018.5895. Epub 2019 Apr 11.

¹ Department of Radiation Medicine, Oregon Health and Science University, Portland.

No abstract available

Comment on

Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.
Smith JJ, Strombom P, Chow OS, Roxburgh CS, Lynn P, Eaton A, Widmar M, Ganesh K, Yaeger R, Cercek A, Weiser MR, Nash GM, Guillem JG, Temple LKF, Chalasani SB, Fuqua JL, Petkovska I, Wu AJ, Reyngold M, Vakiani E, Shia J, Segal NH, Smith JD, Crane C, Gollub MJ, Gonen M, Saltz LB, Garcia-Aguilar J, Paty PB. Smith JJ, et al. JAMA Oncol. 2019 Apr 1;5(4):e185896. doi: 10.1001/jamaoncol.2018.5896. Epub 2019 Apr 11. JAMA Oncol. 2019. PMID: 30629084 Free PMC article.